Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
CitationTransplantation. 1996, 61(3):509-12
AbstractModerate hyperhomocysteinemia, an independent cardiovascular risk factor, has been reported in renal transplant recipients. In the present study, plasma concentrations of total homocysteine were significantly increased in 120 renal transplant recipients as compared with 60 healthy controls (19.0 +/- 6.9 vs. 11.6 +/- 2.8 mumol/L, P < 0.0001) and as compared with 53 patients without a transplant but with a comparable degree of renal failure (19.0 +/- 6.9 vs. 16.0 4.9 mumol/L, P < 0.01). There was a significant inverse correlation between glomerular filtration rates and plasma homocysteine concentrations in the renal transplant recipients (r = -0.52, P < 0.0001). Groups of renal transplant recipients, with and without cyclosporine, and renal patients without a transplant were studied; these groups were comparable regarding age, sex distribution, glomerular filtration rate, and folate and vitamin B12 concentrations. Renal transplant recipients on cyclosporine had significantly higher plasma homocysteine concentrations than those not on cyclosporine (19.5 +/- 7.6 vs. 16.2 +/- 4.8 mumol/L, P < 0.05), and the patients without a transplant (19.5 +/- 7.6 vs. 16.0 +/- 4.9 mumol/L, P < 0.01). Thus, the hyperhomocysteinemia of renal transplant recipients not treated with cyclosporine, and that of renal patients without a transplant probably is explained by the same mechanism: renal insufficiency. An additional mechanism seems to operate in renal transplant recipients treated with cyclosporine. The lack of correlation between the concentrations of plasma homocysteine and red cell folate in these patients suggests that cyclosporine interferes with folate-assisted remethylation of homocysteine. Plasma homocysteine concentrations were significantly increased in 24 patients with a history of atherosclerotic complications as compared with the remaining 96 renal transplant recipients (20.8 +/- 4.4 vs. 18.5 +/- 7.3 mumol/L, P < 0.01).
DescriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links field
- Hyperhomocyst(e)inemia in renal transplant recipients with and without cyclosporine.
- Authors: Ducloux D, Fournier V, Rebibou JM, Bresson-Vautrin C, Gibey R, Chalopin JM
- Issue date: 1998 Apr
- Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients.
- Authors: Födinger M, Wölfl G, Fischer G, Rasoul-Rockenschaub S, Schmid R, Hörl WH, Sunder-Plassmann G
- Issue date: 1999 Mar
- Plasma homocysteine levels in renal transplanted patients on cyclosporine or tacrolimus therapy: effect of treatment with folic acid.
- Authors: Fernández-Miranda C, Gómez P, Díaz-Rubio P, Estenoz J, Carillo JL, Andrés A, Morales JM
- Issue date: 2000 Apr
- Hyperhomocysteinemia and assessment of its associated factors in renal transplant recipients: a single-center study in northern Iran.
- Authors: Monfared A, Azimi SZ, Kazemnezhad E, Khosravi M, Lebadi M, Mirzajani E, Ashtiani MN
- Issue date: 2014 Jul 15
- Influence of anticalcineurinic therapy in plasma homocysteine levels of renal transplant recipients: a prospective study.
- Authors: Laurés AS, Gomez E, Alvarez V, Coto E, Baltar J, Alvarez-Grande J
- Issue date: 2003 Aug